7. CONCLUSION
Our meta-analysis suggests that statin pre-treatment before cardiac
surgery is not associated with a significant reduction of POAF
occurrence. Severe heterogeneity between the considered study does
exist. Until the results of the START-CABG trial are available and
considering the potential acute kidney injury, we discourage statin
pre-treatment in preventing POAF.